NAP1L4 inhibitors are a class of chemical compounds that specifically target and inhibit the NAP1L4 (Nucleosome Assembly Protein 1-Like 4) protein, which plays a critical role in chromatin dynamics and nucleosome assembly. NAP1L4 is part of the NAP family of proteins, known for their involvement in the regulation of histone transport and the assembly of nucleosomes, which are fundamental units of chromatin structure. NAP1L4 is thought to function as a histone chaperone, facilitating the deposition of histones onto DNA, thereby contributing to chromatin remodeling and maintaining proper chromatin structure. By inhibiting NAP1L4, researchers can explore how disruption of histone handling and nucleosome assembly affects gene regulation, chromatin organization, and overall genomic stability.
The mechanism of NAP1L4 inhibitors generally involves blocking the interaction of NAP1L4 with histones or interfering with its ability to assist in nucleosome assembly. These inhibitors might bind to the protein's histone-binding domain, preventing it from interacting with histones, or they might alter the protein's structure through allosteric modulation, rendering it unable to perform its chaperone function. Structurally, NAP1L4 inhibitors may resemble the natural substrates of the protein or contain specific groups that interact with key residues involved in histone binding. The use of these inhibitors allows researchers to study the effects of impaired nucleosome assembly on chromatin structure, transcription regulation, and DNA repair mechanisms. Understanding the role of NAP1L4 and the consequences of its inhibition provides valuable insights into the broader processes that govern chromatin dynamics and how these processes influence gene expression and cellular functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could downregulate NAP1L4 by inhibiting histone deacetylase, which may result in a condensed chromatin state less conducive to transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine could lead to the hypomethylation of gene promoters, potentially decreasing the transcription of NAP1L4. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine may reduce the methylation levels of the NAP1L4 gene promoter, thereby decreasing its transcriptional activity and subsequent protein expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid could decrease NAP1L4 expression by inhibiting histone deacetylases, leading to the accumulation of acetylated histones and altered gene expression profiles. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin may inhibit the mTOR signaling pathway, which could result in reduced protein synthesis, including the downregulation of NAP1L4. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may lead to the downregulation of NAP1L4 by enhancing the deacetylation of histones through activation of sirtuin proteins, altering gene expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could inhibit the transcription factor NF-kB, which may be involved in the transcriptional activation of NAP1L4, leading to its decreased expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid might downregulate NAP1L4 by binding to retinoic acid receptors that interact with promoter regions of genes, altering transcriptional activity. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate may lead to a decrease in NAP1L4 expression by disrupting folate metabolism, thus affecting the availability of nucleotides for DNA and RNA synthesis. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea could inhibit ribonucleotide reductase, leading to a reduction in deoxyribonucleotide pools, which could result in decreased NAP1L4 expression due to limited DNA synthesis. | ||||||